Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
2.800
-0.060 (-2.10%)
At close: Jul 2, 2024, 4:00 PM
2.940
+0.140 (5.00%)
After-hours: Jul 2, 2024, 6:14 PM EDT
Elevation Oncology Market Cap
Elevation Oncology has a market cap or net worth of $152.99 million as of July 2, 2024. Its market cap has increased by 313.48% in one year.
Market Cap
152.99M
Enterprise Value
79.75M
1-Year Change
313.48%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since the IPO on June 25, 2021, Elevation Oncology's market cap has decreased from $365.16M to $152.99M, a decrease of -58.10%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 156.30M | 585.53% |
| Dec 29, 2023 | 22.80M | 3.17% |
| Dec 30, 2022 | 22.10M | -84.19% |
| Dec 31, 2021 | 139.80M | -61.71% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TriSalus Life Sciences | 149.92M |
| Atossa Therapeutics | 149.65M |
| Quantum-Si incorporated | 148.91M |
| Caribou Biosciences | 148.12M |
| ClearPoint Neuro | 147.80M |
| InfuSystem Holdings | 145.45M |
| Acumen Pharmaceuticals | 145.39M |
| Rigel Pharmaceuticals | 144.33M |